Rasna Therapeutics

    OverviewSuggest Edit

    Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. The company's primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. Rasna Therapeutics' clinical program is based on three druggable intervention points with a potential to improve safety and efficacy of current AML combination therapies.

    TypePublic
    Founded2013
    HQNew York, US
    Websiterasna.com

    Locations

    Rasna Therapeutics is headquartered in
    New York, United States

    Location Map

    Latest Updates

    Employees (est.) (Feb 2019)5(-50%)
    Revenue (FY, 2017)$0

    Rasna Therapeutics Office Locations

    Rasna Therapeutics has offices in New York and Greater London
    New York, US (HQ)
    420 Lexington Ave #2525
    Greater London, GB
    55 Park Ln
    Show all (2)

    Rasna Therapeutics Financials and Metrics

    Rasna Therapeutics Revenue

    USD

    Net income (Q2, 2019)

    (265.4k)

    EBIT (Q2, 2019)

    (263.3k)

    Cash (31-Mar-2019)

    42.4k
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Revenue

    General and administrative expense

    40.0k16.8k62.2k1.0m2.5m

    R&D expense

    1.6m324.6k

    Operating expense total

    40.0k16.8k62.2k4.5m4.1m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Revenue

    General and administrative expense

    14.2k3.5k3.4k975.04.2k1.8k248.7k597.0k825.0k644.5k184.6k198.9k

    R&D expense

    807.3k277.3k32.6k136.1k75.0k

    Operating expense total

    14.2k3.5k3.4k975.04.2k1.8k1.8m1.2m1.1m809.4k399.3k263.3k
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Cash

    6.3k35.0134.04.0m42.7k

    Current Assets

    6.3k35.0134.04.2m347.5k

    PP&E

    7.0k5.4k

    Goodwill

    2.7m2.7m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Cash

    25.0k20.8k3.5k1.7k134.0134.03.7m3.3m539.4k20.4k87.6k42.4k

    Accounts Receivable

    14.2k

    Current Assets

    25.0k20.8k3.5k1.7k134.0134.03.7m3.4m691.9k287.4k287.3k162.8k

    PP&E

    6.2k8.0k6.8k4.1k2.8k
    Annual
    USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

    Net Income

    (40.0k)(16.8k)(62.2k)(4.4m)(4.1m)

    Depreciation and Amortization

    3.5k4.8k

    Accounts Payable

    375.03.8k50.5k978.8k

    Cash From Operating Activities

    (40.0k)(12.9k)(11.5k)(3.0m)(2.6m)
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2016Q3, 2016Q2, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

    Net Income

    (21.7k)(25.2k)(3.4k)(7.0k)(2.1m)(1.2m)(2.9m)(3.7m)(401.3k)(666.7k)

    Depreciation and Amortization

    865.03.1k4.4k1.3k2.7k

    Accounts Payable

    650.0575.06.5k(82.0)109.2k194.2k(125.8k)199.1k112.8k150.5k

    Cash From Operating Activities

    (21.4k)(25.5k)(2.9k)(7.1k)(1.4m)(758.1k)(2.0m)(2.5m)(56.2k)(100.3k)
    USDY, 2019

    Financial Leverage

    1.9 x
    Show all financial metrics

    Rasna Therapeutics Online and Social Media Presence

    Embed Graph

    Rasna Therapeutics Frequently Asked Questions

    • When was Rasna Therapeutics founded?

      Rasna Therapeutics was founded in 2013.

    • How many employees does Rasna Therapeutics have?

      Rasna Therapeutics has 5 employees.

    • Who are Rasna Therapeutics competitors?

      Competitors of Rasna Therapeutics include Dicerna Pharmaceuticals, LAM Therapeutics and Urogen Pharma.

    • Where is Rasna Therapeutics headquarters?

      Rasna Therapeutics headquarters is located at 420 Lexington Ave #2525, New York.

    • Where are Rasna Therapeutics offices?

      Rasna Therapeutics has offices in New York and Greater London.

    • How many offices does Rasna Therapeutics have?

      Rasna Therapeutics has 2 offices.